The role and importance of TLRs (Toll-Like Receptors) in immunity;Rola i znaczenie Receptorów Toll-Podobnych w odporności

Postepy Mikrobiologii

Volumn 45, Issue 3, 2006, Pages 221-231

  Deptuła, Wiesław ^a   Tokarz Deptuła, Beata ^a   Niedźwiedzka, Paulina ^a  

^a UNIVERSITY OF SZCZECIN   (Poland)

Author keywords

Pathogen molecular patterns PAMP; TLR

Indexed keywords

GLYCOLIPID; HEAT SHOCK PROTEIN 60; LIPOARABINOMANNAN; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 12; TOLL LIKE RECEPTOR 13; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; ZYMOSAN;

ARTICLE; BACTERIUM DETECTION; FUNGAL DETECTION; IMMUNE SYSTEM; IMMUNITY; INFECTION; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; VIRUS DETECTION;

BACTERIA (MICROORGANISMS);

EID: 33845498476     PISSN: 00794252     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Abel B., Thieblemont N., Quesniaux V.J.F., Brown N.: Toll-like receptor 4 expressing is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immun. 169, 3155-3162 (2002)
2. Aderem A.: Phagocytosis and the inflammatory response. J. Infect. Dis. 187, 340-345 (2003)
3. Akira S., Takeda K.: Toll-like receptor signalling. Immunology, 4, 499-511 (2004)
4. Alexopoulou L., Holt A., Medzhitov R., Flavell R.: Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature, 413, 732-738 (2001)
5. Athman R., Philpott D.: Innate immunity via Toll-like receptors and Nod proteins. Curr. Opinion Microbiol. 7, 25-32 (2004)
6. Backhed F., Normark S., Richter-Dahlfors A.: TLR4-dependent lipopolysaccharide signalling in epithelial cells is independent of extracellular protease activity. Cellular Microbiol. 4, 297-303 (2002)
7. Barton G.M., Medzhitov R.: Linking Toll-like receptors to IFN-ab expression. Nature Immun. 4, 432-433 (2003)
8. Bell J.: Living without Toll-like receptors. Nature Rev. Immun. 3, 261 (2003)
9. Bell J.K., Mullen G.E.D., Leifer C.A., Mazzoni A., Davies D.R., Segal D.M.: Leucine rich repeats and pathogen recognition in Toll-like receptors. Trends Immun. 24, 528-533 (2003)
10. Beutler B.: TLR4: central component of the sole mammalian LPS sensor. Curr. Opinion Immun. 12, 20-26 (2000)
11. Beutler B.: Innate immunity: an overview. Molec. Immun. 40, 845-859 (2004)
12. Beutler B.: Inferences, questions and possibilities in toll-like receptor signalling. Nature, 430, 257-263 (2004)
13. Beutler B.: Toll-like receptors and their place in immunology. Nature, 430, 498 (2004)
14. Beutler B., Hoebe K., Du X., Ulevitch R.J.: How we detect microbes and respond to them: the toll-like receptors and their transducers. J. Leuk. Biol. 74, 479-485 (2003)
15. Beutler B., Wagner H.: Toll-like receptor family members and their ligands. Curr. Topics Microbiol. Immun. 270, 121-143 (2002)
16. Biragyn A., Ruffini P.A., Leifer C. A., Klyushnenkova E., Shakhov A., Chertov O.: Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science, 298, 1025-1029 (2002)
17. Boone D.L., Turer E.E., Lee E.G., Ahmad R.C., Wheeler M.T., Tsui C., Hurley P., Chien M., Chai S., Hitotsumatsu O., McNally E., Pickart C., Ma A.: The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nature Immun. 5, 1052-1060 (2004)
18. Brint E.K., Xu D., Liu H., Dunne A., McKenzie A.N.J., O'Neill L., Liew F.Y.: ST2 is an inhibitor of interleukin 1 receptor and toll-like receptor 4 signaling and maintains endotoxin tolerance. Nature Immun. 5, 373-379 (2004)
19. Brunham R.C., Rey-Ladino J.: Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nature Rev. Immun. 5, 149-161 (2005)
20. Carneiro L.A.M., Travassos L.H., Philpott D.J.: Innate immune recognition of microbes through Nod1 and Nod2: implications for disease. Microbes Infect. 6, 609-616 (2004)
21. Chiara B., Mortarino M., Comazzi S., Bandi C., Franceschi A., Genchi C.: Expression and function of Toll-like receptor 2 in canine blood phagocytes. Vet. Immun. Immunopathol. 104, 15-19 (2005)
22. Cook D.N., Pisetsky D.S., Schwartz D.A.: Toll-like receptors in the pathogenesis of human disease. Nature Immun. 5, 975-979 (2004)
23. Dabbagh K., Dahl M.E., Stepick-Biek P., Lewis D.B.: Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J. Immun. 168, 4524-4531 (2002)
24. Diebold S.S., Kaisho T., Hemmi H., Akira S., Sousa C.R.: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science, 303, 1529-1531 (2004)
25. Doyle S.E., O'Connell R.O., Vaidya S.A., Chow E.K., Yee K., Cheng G.: Toll-like receptor 3 mediates potent antiviral response than Toll-like receptor 4. J. Immun. 170, 3565-3571 (2003)
26. Doyle S.E., O'Connell R.M., Miranda G.A., Vaidya S.A., Chow E.K., Liu P.T., Suzuki N., Modlin R.L., Yeh W.-C., Lane T.F., Cheng G.: Toll-like receptors inducts a phagocytic gene program through p38. J. Exp. Med. 199, 81-90 (2004)
27. Dutz J.P.: Skin immune responses to peptide and protein antigen are TLR4 independent. Cellular Immun. 226, 16-121 (2003)
28. Dziarski R.: Peptidoglycan recognition proteins (PGRPs). Molec. Immun. 40, 877-886 (2004)
29. Ehl S., Bischoff R., Ostler T., Vallbracht S., Schulte-Mönting J., Poltorak A., Freudenberg M.: The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 34, 1146-1153 (2004)
30. Ferrandon D., Imler J.L., Hoffmann J.A.: Sensing infection in Drosophila: Toll and beyond. Sem. Immun. 16, 43-53 (2004)
31. Fidler H.M., Thurrell W., Johnson N.M., Rook G.A., Mc Fadden J.J.: Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut, 35, 506-510 (1994)
32. Gomes M.S., Florido M., Cordeiro J.V., Teixeira M., Takeuschi O.: Limited role of the toll-like receptor-2 in resistance to Mycobacterium avium. Immunology, 111, 179-185 (2004)
33. Gomi K., Kawasaki K., Kawai Y., Shiozaki M., Nishijima M.: Toll-like receptor 4-MD-2 complex mediates the signal transduction induced by flavollin, an amino acid-containing lipid unique to Flavobacterium meningosepticum. J. Immun. 168, 2939-2943 (2002)
34. Happel K. I., Zheng M., Young E., Quinton L.J., Lockhart E., Ramsay A.J., Shellito J.E., Schurr J.R., Bagby G.J., Nelson S., Kolls J.K.: Roles of Toll-like Receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immun. 170, 4432-4436 (2003)
35. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschining C., Akira S., Lipford G., Wagner H., Bauer S.: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science, 303, 1526-1529 (2004)
36. Hoebe K.: Identification of LPS2 as a key transducer of MyD88-independent TIR signalling. Nature, 424, 743-748 (2003)
37. Hsu L.C., Park J.M., Zhang K., Luo J.L., Maeda S., Kaufman R.J., Eckmann L., Guiney D.G., Karin M.: The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature, 428, 341-345 (2004)
38. Janssens S., Beyaert R.: Role of Toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 16, 637-646 (2003)
39. Johnson G.B., Brunn G. J., Platt J.L.: Activation of mammalian Toll-like receptors by endogenous agonists. Crit. Rev. Immun. 23, 15-14 (2003)
40. Kahlon R., Dutz J.P.: Skin immune responses to peptide and protein antigen are TLR4 independent. Cellular Immun. 226, 116-123 (2003)
41. Kalis C., Kanzler B., Lembo A., Poltorak A., Galanos C., Freudenberg M.A.: Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice. Eur. J. Immun. 33, 798-805 (2003)
42. Kang T.-J., Chae G.-T.: Detection of Toll-like receptor 2 TLR2 mutation in the lepromatous leprosy patients. Immun. Med. Microbiol. 31, 53-58 (2001)
43. Kawai T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., Terai K., Matsuda M., Inoue J.-I., Uematsu S., Takeuchi O., Akira S.: Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immun. 5, 1061-1068 (2004)
44. Khush R. S., Leulier F., Lemaitre B.: Pathogen surveillance-the flies have it. Science, 296, 273-275 (2002)
45. Koedel U., Angele B., Rupprecht T., Wagner H., Roggenkamp A., Pfister H.-W., Kirschning C.J.: Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immun. 170, 438-444 (2003)
46. Kopp E., Medzhitov R.: Recognition of microbial infection by Toll-like receptors. Curr. Opinion Immun. 15, 396-401 (2003)
47. Krutzik S.R., Modlin R.L.: The role of Toll-like receptors in combating mycobacteria. Sem. Immun. 16, 35-41 (2004)
48. Kumaraguru U., Pack C.D., Rouse B.T.: Toll-like receptor ligand links innate and adaptive immune e responses by the production of heat-shock proteins. J. Leuk. Biol. 73, 574-583 (2003)
49. Larski Z.: Postȩp w badaniach nad odpornościa̧ wrodzona̧. Medycyna Wet. 58, 651-654 (2002)
50. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., Lien E., Nilsen N.J., Espevik T., Golenbock D.T.: TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nature Immun. 5, 190-198 (2004)
51. Lebouder E., Rey-Nores J.E., Rushmere N.K., Grigorov M., Lawn S.D., Affolter M., Griffin G.E., Ferrara P., Schiffrin E.J., Morgan B.P., Labeta M.O.: Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immun. 171, 6680-6689 (2003)
52. Lemaitre B.: The road to Toll. Nature Rev. Immunn. 4, 521-527 (2004)
53. Lien E., Golenbock D.T.: Adjuvants and their signaling pathways: beyond TLRs. Nature Immun. 4, 1162-1165 (2003)
54. Ma Y., Liu H., Tu-Rapp H., Thiesen H.J., Ibrahim S.M., Cole S.M., Pope R.M.: Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nature Immun. 5, 380-387 (2004)
55. Martin M., Michalek S.M., Katz J.: Role of innate immune factors in the adjurant activity of monophosphore lipid A. Infect. Immunity, 71, 2498-250 (2003)
56. Medzhitov R.: Toll-like receptors and acquired immunity. Sem. Immun. 16, 23-28 (2004)
57. Medzhitov R., Janawey C.: An ancient system of host defense. Curr. Opinion Immun. 10, 12-15 (1998)
58. Medzhitov R., Preston-Hurlburt P., Janeway C. A.: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388, 394-397 (1997)
59. Meng G.: Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J. Clin. Invest. 113, 1473-1481 (2004)
60. Modlin R. L.: A Toll for DNA vaccines. Nature, 408, 659-660 (2000)
61. Modlin R.L., Doherty P.: Host defense against microbial pathogens - the immune system's weapons of mass destruction. Curr. Opinion Immun. 15, 393-395 (2003)
62. Muneta Y., Uenishi H., Kikuma R., Yoshihara K., Shimoji Y., Hamashima N., Yokomizo Y., Mori Y.: Porcine TLR2 and TLR6: identification and their involvement in Mycoplasma hyopneumoniae infection. J. Interferon Cytokin. Res. 23, 583-590 (2003)
63. Netea M.G., Sutmuller R., Hermann C., Van der Graaf C.A.A., Vea der Meer J.W.M., van Krieken J.H., Hartung T., Adema G., Kullberg B.J.: Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells. J. Immun. 172, 3712-3718 (2004)
64. O'Neill L. A. J.: Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immun. 23, 296-300 (2002)
65. O'Neill L.A.J.: How NOD-ing off leads to Crohn disease. Nature Immun. 8, 776-778 (2004)
66. O'Neill L.A.J.: TLRs: Professor Mechnikov, sit on your hat. Trends Immun. 25, 687-693 (2004)
67. O'Neill L.A.J., Brown Z., Ward S.G.: Toll-like receptors in the spotlight. Nature Immun. 4, 299 (2003)
68. O'Neill L.A.J., Fitzgerald K.A., Bowie A.G.: The Toll-IL-1 receptor adaptor family grows to five members. Trends Immun. 24, 287-290 (2003)
69. Orme I.: Adaptive immunity to mycobacteria. Curr. Opinion Immun. 7, 58-61 (2004)
70. Paterson H.M., Murphy T.J., Purcell E.J., Shelley O., Kriynovich S.J., Lien E., Mannick J.A., Lederer J.A.: Injury primes the innate immune system for enhanced toll-like receptor reactivity. J. Immun. 171, 1473-1483 (2003)
71. Pereira J.P., Girard R., Chaby R., Cumano A., Vieira P.: Monoallelic expression of the murine gene encoding Toll-like receptor 4. Nature Immun. 4, 464-470 (2003)
72. Platt J., Riggs B.L.: The "Adonis Effect": Mayo reaserchers discover genetic basis in mice for aging with strong bones, low body fat. Http://www.mayoclinic.org/news2004-rst/2384. html
73. Prohászka Z., Füst G.: Immunological aspects of heat-shock proteins - the optimum stress of life. Molec. Immun. 41, 29-44 (2004)
74. Reichhart J.M.: TLR5 takes aim at bacterial propeller. Nature Immun. 4, 1159-1164 (2003)
75. Reis e Sousa C.R.: Toll-like receptors and dendritic cells for whom the bug tolls. Sem. Immun. 16, 27-34 (2004)
76. Rozwadowska N., Fiszer D., Kurpisz M.: Cytokines acting trough Toll-like system in human testis. Proc. Immun. Soc. Europ. John Humphrey's School, Zakopane, 9a, 11, 2002
77. Sabroe I., Read R.C., Whyte M.K.B., Dockrell D.H., Vogel S.N., Dower S.K.: Toll-like receptors in health and disease: complex questions remain. J. Immun. 171, 1630-1635 (2003)
78. Shi G.X., Harrison K., Han S.B., Moratz C., Kehrl J.H.: Toll-Like receptor signaling alters the expression of regulator of G protein signaling proteins in dendritic cells: Implications for G protein-coupled receptor signaling. J. Immun. 172, 5175-5184 (2004)
79. Stanley M.A.: Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin. Exp. Dermatol. 27, 571-574 (2002)
80. Szczepański M.J., Góralski M., Mozer-Lisewska I., Samara H., Zeromski J.: Rola receptorów Toll-podobnych w odporności. Post. Biol. Kom. 31, 543-561 (2004)
81. Takeuchi O., Akira S.: Genetic approches to the study of Toll-like receptor function. Microbes Infect. 4, 887-895 (2002)
82. Takeuchi O., Hoshino K.: Differential roles of TLR2 and TLR4 in recognition of gram negative and gram positive bacterial cell wall components. Immunity, 11, 443-451 (1999)
83. Totemeyer S., Foster N., Kaiser P., Maskell D.J., Bryant C.E.: Toll-like receptor expression in C3H/HeN and C3H/HeJ mice during Salmonella enterica serovar Typhimurium infection. Infect. Immun. 71, 6653-6657 (2003)
84. Ulevitch R.J.: Therapeutics targeting the innate immune system. Nature, 4, 512-520 (2004)
85. Vaidya S.A., Cheng G.: Toll-like receptors and innate antiviral responses. Curr. Opinion Immun. 15, 402-407 (2003)
86. Varadaradjalou S., Feger F., Thieblemont N., Hamouda N.B., Pleau J.M., Dy M., Arock M.: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33, 899-906 (2003)
87. Vasselon T., Hanlon W.A., Wright S.D., Detmers P.A.: Toll-like receptors 2 (TLR2) mediates activated MAP kinase p38. J. Leuk. Biol. 71, 503-510 (2002)
88. Verthelyi D., Zeuner R.A.: Differential signaling by CpG in DCs and B cells: not just TLR9. Trends Immun. 24, 519-522 (2003)
89. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Hurre M.R., Coyle A.J., Di Stefano P.S., Sansonetti P.J., Labigner A., Bertin J., Philpot D.J., Ferro R.L.: Nodi responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nature Immul. 5, 1166-1174 (2004)
90. Wagner H.: The immunology of the TLRS subfamily. Trends Immun. 25, 381-386 (2004)
91. Watanabe T., Kitani A., Murray P.J., Strober W.: NOD2 is negative regulator of Toll-like receptor 2-medited T helper type 1 response. Nature Immun. 5, 800-808 (2004)
92. Werkling D., Jungi T.W.: TOLL-like receptors linking innate and adaptive immune response. Vet. Immun. Immunopath. 91, 1-12 (2003)
93. West M.A., Wallin P.A., Mathews S.P., Svensson H.G., Zaru R., Ljunggren H.G., Prescott A.R., Watts C.: Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science, 305, 1153-1157 (2004)
94. Yamamoro M.: Role of adaptor TRIP in the MyD88-independent Toll-like receptor signalling pathway. Science, 301, 640-643 (2003)
95. Yamamoto M., Takeda K., Akira S.: TIR domain-containing adaptors define the specificity of TLR signalling. Molec. Immun. 40, 861-868 (2004)
96. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmi H., Hoshino K., Kaisho T., Kuwata H., Takeuschi O., Takeshige K., Saitoh T., Yamaoka S., Yamamoto S., Muta T., Takeda K., Akira S.: Regulation of Toll/IL-1-receptor mediated gene expression by the inducible nuclear protein. Nature, 430, 218-222 (2004)
97. Zarember K.A., Godowski P.J.: Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immun. 168, 554-561 (2002)
98. Zhang Y., Blattman J.M., Kennedy N.J., Duong J., Nguyen T., Wang Y., Davis R.J., Greenberg P.D., Flavell R.A., Dong C.: Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature, 430, 793-797 (2004)
99. Zhang D., Zhang G., Hayden M.S., Greenblatt M.B., Flavell R.A., Ghosh S.: A Toll-like receptor that prevents infection by uropathogenic bacteria. Science, 303, 1522-1526 (2004)